ChemPartner PharmaTech Co., Ltd. — Investor Relations & Filings
ChemPartner PharmaTech Co., Ltd. is a global research and development organization providing comprehensive drug discovery and development services. Operating as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), the company supports pharmaceutical and biotechnology clients through an integrated service platform. Core capabilities include medicinal chemistry, biology, pharmacology, drug metabolism and pharmacokinetics (DMPK), and toxicology. The organization also offers specialized expertise in biologics discovery, protein engineering, and antibody development. ChemPartner facilitates the transition from early-stage research to clinical development through its pharmaceutical development and manufacturing capabilities, utilizing advanced technology to accelerate the discovery and production of novel therapeutic agents.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于调增2019年度公司与关联方日常关联交易预计额度的公告 | 2019-12-11 | Chinese | |
| 关于全资孙公司凯惠药业（上海）有限公司涉嫌污染环境案的进展公告 | 2019-11-20 | Chinese | |
| 关于股东在同一控制下股权变动的进展公告 | 2019-10-29 | Chinese | |
| 2019年第三季度报告披露的提示性公告 | 2019-10-27 | Chinese | |
| 2019年第三季度报告全文 | 2019-10-27 | Chinese | |
| 关于股东在同一控制下股权变动的提示性公告 | 2019-10-15 | Chinese |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2019
15 filings
| |||||
| 36032235 | 关于调增2019年度公司与关联方日常关联交易预计额度的公告 | 2019-12-11 | Chinese | ||
| 36032222 | 关于全资孙公司凯惠药业（上海）有限公司涉嫌污染环境案的进展公告 | 2019-11-20 | Chinese | ||
| 36032212 | 关于股东在同一控制下股权变动的进展公告 | 2019-10-29 | Chinese | ||
| 36032202 | 2019年第三季度报告披露的提示性公告 | 2019-10-27 | Chinese | ||
| 36032195 | 2019年第三季度报告全文 | 2019-10-27 | Chinese | ||
| 36032171 | 关于股东在同一控制下股权变动的提示性公告 | 2019-10-15 | Chinese | ||
| 36032162 | 2019年前三季度业绩预告 | 2019-10-15 | Chinese | ||
| 36032155 | 关于终止非公开发行A股股票事项的公告 | 2019-10-09 | Chinese | ||
| 36032144 | 第四届监事会第十二次会议决议公告 | 2019-10-09 | Chinese | ||
| 36032138 | 第四届董事会第十四次会议决议公告 | 2019-10-09 | Chinese | ||
| 36032124 | 北京国枫律师事务所关于公司2017年股票期权激励计划之调整事项的法律意见书 | 2019-10-09 | Chinese | ||
| 36032108 | 关于调整2017年股票期权激励计划行权价格的公告 | 2019-10-09 | Chinese | ||
| 36032096 | 独立董事关于第四届董事会第十四次会议相关事项的事前认可意见 | 2019-10-09 | Chinese | ||
| 36032087 | 独立董事关于第四届董事会第十四次会议相关事项的独立意见 | 2019-10-09 | Chinese | ||
| 36032077 | 关于投资设立香港子公司的公告 | 2019-10-09 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
ChemPartner PharmaTech Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55161/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55161 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55161 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55161 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55161}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ChemPartner PharmaTech Co., Ltd. (id: 55161)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.